KA
Kintegral Advisory’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.2M | Sell |
173,074
-261
| -0.2% | -$6.33K | 0.38% | 79 |
|
2025
Q1 | $4.39M | Sell |
173,335
-582
| -0.3% | -$14.7K | 0.44% | 70 |
|
2024
Q4 | $4.61M | Sell |
173,917
-8,102
| -4% | -$215K | 0.44% | 63 |
|
2024
Q3 | $5.27M | Sell |
182,019
-2,385
| -1% | -$69K | 0.48% | 60 |
|
2024
Q2 | $5.16M | Buy |
184,404
+130,606
| +243% | +$3.65M | 0.49% | 54 |
|
2024
Q1 | $1.49M | Sell |
53,798
-168
| -0.3% | -$4.66K | 0.15% | 134 |
|
2023
Q4 | $1.55M | Sell |
53,966
-344
| -0.6% | -$9.9K | 0.17% | 130 |
|
2023
Q3 | $1.8M | Sell |
54,310
-32
| -0.1% | -$1.06K | 0.22% | 109 |
|
2023
Q2 | $1.99M | Hold |
54,342
| – | – | 0.24% | 107 |
|
2023
Q1 | $2.22M | Sell |
54,342
-2,919
| -5% | -$119K | 0.29% | 102 |
|
2022
Q4 | $2.93M | Sell |
57,261
-9,351
| -14% | -$479K | 0.39% | 88 |
|
2022
Q3 | $2.92M | Hold |
66,612
| – | – | 0.4% | 68 |
|
2022
Q2 | $3.49M | Buy |
66,612
+1,411
| +2% | +$74K | 0.45% | 59 |
|
2022
Q1 | $3.38M | Buy |
65,201
+1,459
| +2% | +$75.5K | 0.37% | 65 |
|
2021
Q4 | $3.76M | Hold |
63,742
| – | – | 0.39% | 59 |
|
2021
Q3 | $2.74M | Hold |
63,742
| – | – | 0.32% | 75 |
|
2021
Q2 | $2.5M | Hold |
63,742
| – | – | 0.29% | 83 |
|
2021
Q1 | $2.31M | Hold |
63,742
| – | – | 0.3% | 86 |
|
2020
Q4 | $2.35M | Hold |
63,742
| – | – | 0.32% | 77 |
|
2020
Q3 | $2.34M | Sell |
63,742
-2,052
| -3% | -$75.3K | 0.35% | 72 |
|
2020
Q2 | $2.15M | Hold |
65,794
| – | – | 0.35% | 76 |
|
2020
Q1 | $2.15M | Buy |
65,794
+7,361
| +13% | +$240K | 0.42% | 68 |
|
2019
Q4 | $2.29M | Hold |
58,433
| – | – | 0.42% | 71 |
|
2019
Q3 | $2.1M | Hold |
58,433
| – | – | 0.42% | 71 |
|
2019
Q2 | $2.53M | Hold |
58,433
| – | – | 0.51% | 48 |
|
2019
Q1 | $2.48M | Sell |
58,433
-1,919
| -3% | -$81.5K | 0.52% | 50 |
|
2018
Q4 | $2.63M | Buy |
+60,352
| New | +$2.63M | 0.78% | 33 |
|